Skip to content
Open access

Systemic and pulmonary hemodynamic effects of inhaled high-concentration nitric oxide in patients with coronary artery disease

Oct 2026 · Russian Journal of Cardiology · 0 citations · 14 references

TL;DR

Inhalation of nitric oxide at a concentration of 200 ppm for 30 minutes does not affect systemic hemodynamic parameters, demonstrating its safety profile in CAD patients after CABG.

Abstract

Aim.  To evaluate the acute hemodynamic effects of inhaled nitric oxide (iNO) 200 ppm for prevention of nosocomial pneumonia (NP) in patients with coronary artery disease (CAD) after bypass grafting (CABG), as well as to confirm the beneficial effect of high-concentration iNO on pulmonary circulation and rule out any adverse effects on systemic circulation. Material and methods.  A subanalysis of the randomized, single-blind RECORD study (www.clinicaltrials.gov, № NCT06162455) was conducted. We analyzed 12 patients with CAD and risk factors for NP. Two days after CABG, they underwent the first iNO procedure in a cycle of 200 ppm inhalations for 30 minutes twice daily for 5 days to prevent CAD. NO inhalations were performed using a Tianox-V system (Russia). During iNO, blood pressure, heart rate, and blood oxygen saturation (SpO 2 ) were continuously monitored. Left and right cardiac parameters, systemic and pulmonary hemodynamics were assessed using a Vivid 95 ultrasound diagnostic system (GE HealthCare, USA). Parameters were recorded at baseline and at 10 and 30 minutes of iNO. Statistical analysis was performed using SPSS. Results.  Against the background of iNO, we revealed a decrease in the tricuspid regurgitation velocity (TRV) (p=0,007), right ventricular systolic pressure (RVSP) (p<0,001), an increase acceleration time/ejection time ratio (AT/ET) in the right ventricular (RV) outflow tract (p=0,012), an increase in tricuspid annular plane systolic excursion (TAPSE) (p<0,001), a decrease in inferior vena cava (IVC) diameter and increase in percentage of inspiratory collapse (p=0,045) by the 10 th  minute of iNO. Changes in right heart and pulmonary artery pressure (TRV, RVSP, AT/ET ratio) were recorded by the 10 th  minute of iNO administration and remained unchanged as inhalation continued. Increases in TAPSE and changes in IVC loading parameters became significant by the 30 th  minute. Blood pressure, heart rate, and SpO 2  remained unchanged throughout the inhalation period. Conclusion.  Inhalation of nitric oxide at a concentration of 200 ppm for 30 minutes does not affect systemic hemodynamic parameters, demonstrating its safety profile in CAD patients after CABG. This leads to selective vasodilation of the pulmonary artery and its branches, which revealed a decrease in systolic and mean pressure and an indirect decrease in RV afterload with an improvement in its systolic function. ere detected.

Read PDF

Similar papers

Review Sep 2026

The Use of Inhaled Nitric Oxide After Pediatric Cardiac Surgery.

A retrospective analysis reviewed all patients within the Pediatric Cardiac Critical Care Consortium (PC4) clinical registry, representing 63 North American cardiac intensive care units (CICU), who underwent cardiac surgery from August 2014 to August 2023 to describe contemporary iNO use and its relationship to patient...

J. Diddle, J. Patregnani, Claudia A. Algaze et al. · 0 citations
Review Oct 2026

Pulsed administration of inhaled nitric oxide: Development, clinical applications, and future perspectives.

Nitric oxide (NO) gas continues to be a widely studied and versatile treatment given its broad spectrum of physiological effects such as pulmonary vasodilation, improvement of oxygenation, anti-inflammatory, and antimicrobial effects. The idea of administering a pulsed dose of inhaled NO (PiNO) at the beginning of inha...

Jonathan Thein, H. Wanderley, Andrea Bolchini et al. · 0 citations
Open access Sep 2026

A Retrospective Analysis of Inhaled Nitric Oxide and Outcomes in Mechanically Ventilated Patients with COVID-19 ARDS

Background: Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator used as rescue therapy in acute respiratory distress syndrome (ARDS) for transient improvement in oxygenation. Although multiple studies demonstrate improvements in oxygenation parameters, iNO has not consistently shown a mortality benefit or r...

Abbie Evans, Sheng-Ping Yang, Noella Vinan-Vega et al. · 0 citations
Aug 2026

Clinical utility of pulmonary artery catheter derived hemodynamic parameters: a prospective clinical study

Background. Induction of anesthesia and mechanical ventilation frequently lead to arterial hypotension whose nature can be elucidated through analysis of volumetric and pressure-derived hemodynamic parameters. These include measured or calculated, including indexed, indicators of the left and right cardiac chambers (le...

A. K. Kolotukhin, A. Bakanov, V. S. Shabaev et al. · 0 citations
Open access Jan 2026

Aerosolized prostaglandin E1 improves oxygenation during one-lung ventilation: A dose-finding randomized controlled trial

Highlights • Nebulized PGE1improves oxygenation during OLV under 60% FiO2.• PGE1 reduces intrapulmonary shunt (Qs/Qt) without increasing PPCs.• The 0.3 μg/kg dose provides the greatest oxygenation benefit.• High dose PGE1 is associated with lower CPIS (exploratory, surrogate endpoint).• Hemodynamic monitoring is advise...

Peng-Xi Li, Xin-Yang Hu, Peng-Yi Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.